142 related articles for article (PubMed ID: 311683)
1. A clinical and pharmacological study of high-dose methotrexate with minimal leucovorin rescue.
Stoller RG; Kaplan HG; Cummings FJ; Calabresi P
Cancer Res; 1979 Mar; 39(3):908-12. PubMed ID: 311683
[No Abstract] [Full Text] [Related]
2. Clinical and pharmacological studies of methotrexate-minimal leucovorin rescue plus fluorouracil.
Wiemann MC; Cummings FJ; Kaplan HG; Spremulli EN; Doolittle CH; Calabresi P
Cancer Res; 1982 Sep; 42(9):3896-900. PubMed ID: 6980707
[No Abstract] [Full Text] [Related]
3. Cytokinetic comparison of thymidine and leucovorin rescue of marrow in humans after exposure to high-dose methotrexate.
Howell SB; Krishan A; Frei E
Cancer Res; 1979 Apr; 39(4):1315-20. PubMed ID: 311245
[TBL] [Abstract][Full Text] [Related]
4. High-dose methotrexate with leucovorin rescue.
Akahoshi M
Cancer Nurs; 1978 Aug; 1(4):319-25. PubMed ID: 307982
[No Abstract] [Full Text] [Related]
5. High-dose methotrexate with leucovorin rescue in ovarian cancer: a phase II study.
Parker LM; Griffiths CT; Yankee RA; Knapp RC; Canellos GP
Cancer Treat Rep; 1979 Feb; 63(2):275-9. PubMed ID: 312692
[TBL] [Abstract][Full Text] [Related]
6. High-dose methotrexate-citrovorum factor rescue in the management of brain tumors.
Djerassi I; Kim JS; Shulman K
Cancer Treat Rep; 1977 Jul; 61(4):691-4. PubMed ID: 301782
[No Abstract] [Full Text] [Related]
7. Phase II clinical trial with high-dose methotrexate therapy and citrovorum factor rescue.
Isacoff WH; Eilber F; Tabbarah H; Klein P; Dollinger M; Lemkin S; Sheehy P; Cone L; Rosenbloom B; Sieger L; Block JB
Cancer Treat Rep; 1978 Sep; 62(9):1295-304. PubMed ID: 356984
[TBL] [Abstract][Full Text] [Related]
8. Phase I trial of high-dose methotrexate with modified citrovorum factor rescue.
Jacobs SA; Santicky MJ
Cancer Treat Rep; 1978 Mar; 62(3):397-9. PubMed ID: 348306
[No Abstract] [Full Text] [Related]
9. [Treatment of malignant neoplasms in advanced stages with HDMTX-CF Rescue (high-dose methotrexate-citrovorum factor rescue)].
Paparopoli G; Agostara B; Di Girolamo G
Clin Ter; 1981 May; 97(3):271-81. PubMed ID: 6974631
[No Abstract] [Full Text] [Related]
10. High-dose methotrexate with citrovorum factor rescue: predictive value of serum methotrexate concentrations and corrective measures to avert toxicity.
Nirenberg A; Mosende C; Mehta BM; Gisolfi AL; Rosen G
Cancer Treat Rep; 1977 Aug; 61(5):779-83. PubMed ID: 302143
[No Abstract] [Full Text] [Related]
11. Thymidine rescue of high-dose methotrexate in humans.
Howell SB; Ensminger WD; Krishan A; Frei E
Cancer Res; 1978 Feb; 38(2):325-30. PubMed ID: 637906
[TBL] [Abstract][Full Text] [Related]
12. High-dose methotrexate in malignant gliomas.
Shapiro WR
Cancer Treat Rep; 1977 Jul; 61(4):753-6. PubMed ID: 301785
[No Abstract] [Full Text] [Related]
13. Use of plasma pharmacokinetics to predict and prevent methotrexate toxicity.
Stoller RG; Hande KR; Jacobs SA; Rosenberg SA; Chabner BA
N Engl J Med; 1977 Sep; 297(12):630-4. PubMed ID: 302412
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of high-dose infusions of methotrexate followed by leucovorin in carcinoma of the head and neck.
Mitchell MS; Wawro NW; DeConti RC; Kaplan SR; Papac R; Bertino JR
Cancer Res; 1968 Jun; 28(6):1088-94. PubMed ID: 4298056
[No Abstract] [Full Text] [Related]
15. [Moderate dose methotrexate with citrovorum factor rescue therapy in the treatment of head and neck cancer].
Inuyama Y; Hiroto I; Taketa C; Horiuchi M; Mashino S; Fujii M; Matsuura S; Satake B; Takeoda S; Nishijima W; Okuda M; Sakaguchi K; Tanigaito Y; Imakirei M; Konno T; Hirokawa T; Takada K; Ono I; Saitoh H; Takemiya S; Shimada F; Omura K; Miyake H; Fujii K; Kawabe Y; Kondoh T; Komiyama S; Yanagida T; Matsumura Y; Hirano M; Araki S
Gan To Kagaku Ryoho; 1982 Dec; 9(12):2193-200. PubMed ID: 6764099
[TBL] [Abstract][Full Text] [Related]
16. Significance of the 48-hour plasma level in high-dose methotrexate regimens.
Perez C; Wang YM; Sutow WW; Herson J
Cancer Clin Trials; 1978; 1(2):107-11. PubMed ID: 316368
[TBL] [Abstract][Full Text] [Related]
17. High dose methotrexate with citrovorum factor in adult resistant lymphoma.
Turman S; Coleman M; Silver RT; Pasmantier M
Cancer; 1977 Dec; 40(6):2823-8. PubMed ID: 338137
[TBL] [Abstract][Full Text] [Related]
18. [High dose methotrexate with leucovorin rescue in the treatment of malignant lymphoma].
Sampi K; Hattori M
Gan To Kagaku Ryoho; 1982 Jul; 9(6):1068-73. PubMed ID: 6985194
[TBL] [Abstract][Full Text] [Related]
19. Clinical trials and pharmacokinetics of intermittent high-dose methotrexate-"leucovorin rescue" for children with malignant tumors.
Pratt CB; Roberts D; Shanks EC; Warmath EL
Cancer Res; 1974 Dec; 34(12):3326-31. PubMed ID: 4547680
[No Abstract] [Full Text] [Related]
20. [Phase II trial of high dose methotrexate with citrovorum factor "rescue" for hematological malignancies].
Ueda T; Kubota Y; Saigo K; Tanaka T; Takubo T; Shibata H; Nakamura H; Masaoka T; Yoshitake J; Ishigami S
Rinsho Ketsueki; 1982 Jun; 23(6):854-61. PubMed ID: 6983592
[No Abstract] [Full Text] [Related]
[Next] [New Search]